Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

PolandBack to Poland

Clinical trials in Bialystok – page 15

579 clinical trials in Bialystok, Poland across 9 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Bialystok at a glance
579
clinical trials
  • Research sites9
Type of trial
Recruitment status
Quick filters

579 trials in Bialystok

Open in trial search

Cervix carcinoma

Recruiting

Study on the Effectiveness of Volrustomig in Women with High-Risk Locally Advanced Cervical Cancer After Chemoradiation Therapy

Registered drug
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:AstraZeneca AB

Pulmonary hypertension

Recruiting

Long-term Safety Study of Tadalafil and Macitentan for Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Macitentan
  • Sponsor:Actelion Pharmaceuticals Ltd.

Non-small cell lung cancer

Recruiting

Study of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:MRNA-4157
  • Sponsor:Merck Sharp & Dohme LLC

Chronic kidney disease+1

Recruiting

Study on the Long-Term Safety of Finerenone with ACE Inhibitors or ARBs for Children and Young Adults with Chronic Kidney Disease and Proteinuria

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Chronic lymphocytic leukaemia

Recruiting

Study on Acalabrutinib and Obinutuzumab vs. Venetoclax and Obinutuzumab for Newly Diagnosed Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Specjalistyczny Szpital Im. Dra Alfreda Sokolowskiego

Non-Hodgkin's lymphoma

Recruiting

Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Cyclophosphamide
  • Sponsor:Universitaetsklinikum Muenster AöR

Neoplasm+5

Recruiting

Study for Patients with Lung or Urinary Tract Cancer Continuing Treatment with Durvalumab, Infliximab, and Mycophenolate Mofetil

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB

Acute myeloid leukaemia

Recruiting

Study on Personalized Treatment for Acute Myeloid Leukemia Using Cladribine, Daunorubicin, Cytarabine, and Drug Combinations for Specific Patient Groups

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cladribine
  • Sponsor:Medical University Of Lodz

Study on Colchicine for Preventing Artery Narrowing in Patients with Lower Extremity Artery Disease

Recruiting
Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Uniwersytecki Szpital Kliniczny W Opolu

Congenital cystic kidney disease

Recruiting

Study on the Safety and Effects of Tolvaptan for Children with Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Tolvaptan
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Colitis ulcerative

Recruiting

Study Comparing Vedolizumab and Infliximab for Children Aged 6-17 with Ulcerative Colitis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Infliximab
  • Sponsor:Instytut Pomnik Centrum Zdrowia Dziecka

Hormone receptor positive breast cancer

Recruiting

Study Comparing MK-2870 and Pembrolizumab with Chemotherapy for Patients with Advanced Hormone Receptor Positive Breast Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Bialystok

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on bladder cancer treatment using combination therapies, and innovative approaches for advanced breast cancer management. Research includes novel treatments for various solid tumors and gynecological malignancies.

  • Non-muscle invasive bladder cancer treatment
  • Advanced/metastatic breast cancer therapies
  • Gynecological tumor treatments

Investigations emphasize combination therapies and targeted treatment approaches.

02 Neurological & Mental Health

Clinical research targeting early Alzheimer's disease, exploring new treatments to slow disease progression and improve cognitive function.

  • Alzheimer's disease progression
  • Cognitive function assessment
  • Disease-modifying therapies

Focus on developing interventions for early-stage neurological conditions.

03 Inflammatory Conditions

Comprehensive studies on various inflammatory conditions including psoriatic arthritis, plaque psoriasis, and Crohn's disease. Research spans both biologic-naive and experienced patients.

  • Moderate to severe plaque psoriasis
  • Active psoriatic arthritis treatments
  • Chronic rhinosinusitis management

Evaluating novel therapeutic approaches for inflammatory disorders.

04 Metabolic & Cardiovascular Health

Studies addressing obesity, chronic kidney disease, and heart failure prevention. Research includes innovative treatments for weight management and cardiovascular risk reduction.

  • Obesity and weight management
  • Heart failure prevention
  • Chronic kidney disease treatments

Integration of multiple therapeutic approaches for complex metabolic conditions.

Back to PolandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.